Stephane Bancel
Chief Executive Officer at Moderna; Director at Generate Biomedicines. Based in Cambridge, Massachusetts.
- Rank
- 211th of 14,644
- Companies held
- 2
- Largest holding
- MRNA, 99.6% of total
- Latest SEC filing
- Aug 6, 2026
- Listed but not counted
- $3.16B
What the $1.29B is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Moderna MRNA Common Stock | Directly | 6,440,260 | $200.05 | $1.29B | 99.6% | Form 4, Aug 6, 2026 |
| Generate Biomedicines GENB Common Stock | Directly | 460,829 | $10.33 | $4.8M | 0.4% | Form 4, Feb 26, 2026 |
Share counts are the amounts Stephane Bancel reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Stephane Bancel's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Moderna MRNA Common Stock | Indirectly (see filing footnote) Held by an investment fund or partnership | 9,210,686 | $200.05 | $1.84B | — | Form 4, Aug 5, 2026 |
| Moderna MRNA Common Stock | Through OCHA LLC Held by a company or fund the insider manages | 6,564,880 | $200.05 | $1.31B | — | Form 4, Aug 5, 2026 |
| Generate Biomedicines GENB Common Stock | Through OCHA LLC Held by a company or fund the insider manages | 724,160 | $10.33 | $7.5M | — | Form 4, Mar 2, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 208 | George Raymond Zage III Director, Grindr. West Hollywood, CA | $1.31B |
| 209 | Vahe Kuzoyan President, ServiceTitan. Glendale, CA | $1.31B |
| 210 | Tushar Patel 10% owner, Amneal Pharmaceuticals. Newport Beach, CA | $1.31B |
| 211 | Stephane Bancel Chief Executive Officer, Moderna. Cambridge, MA | $1.29B |
| 212 | Carson H. Brice 10% owner, First Citizens BancShares. Smithfield, NC | $1.28B |
| 213 | Arthur D. Levinson Director, Apple. Cupertino, CA | $1.26B |
| 214 | Maurice J. Duca 10% owner, AppFolio. Santa Barbara, CA | $1.26B |
Other Moderna insiders
All MRNA insiders- Robert Langer$2.30BDirector. #136 overall
- Noubar B. Afeyan$446MDirector. #519 overall
- Stephen Hoge$293MPresident. #691 overall
- Paul Sagan$98.8MDirector. #1520 overall
- Juan Andres$25.0MChief Operating Officer. #4249 overall
- Shannon Thyme Klinger$16.3MChief Legal Officer. #6044 overall
Questions
How much stock does Stephane Bancel own?
Stephane Bancel holds $1,293,102,175 in listed stock based on SEC filings and current prices, mostly Moderna (MRNA). That ranks 211th on the Stock Rich List.
Is this Stephane Bancel's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Stephane Bancel last buy or sell stock?
The most recent open-market trade on file is a sale of 124,838 MRNA shares on Aug 5, 2026 at $56.96.